Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease

Pharmacology Biochemistry and Behavior

Volumn 138, Issue , 2015, Pages 96-103

  Wang, Jun ^a,b   He, Can ^a,b   Wu, Wang Yang ^a   Chen, Feng ^c   Wu, Yang Yang ^a   Li, Wei Zu ^a   Chen, Han Qing ^b   Yin, Yan Yan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b HEFEI UNIVERSITY OF TECHNOLOGY   (China)

^c CLEMSON UNIVERSITY   (United States)

Author keywords

Biochanin A; Dopaminergic neuron; Microglia; NADPH oxidase; Oxidative stress; Parkinson's disease

Indexed keywords

BIOCHANIN A; GLUTATHIONE PEROXIDASE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P47PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P67PHOX; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; GENISTEIN; NEUROPROTECTIVE AGENT;

ABNORMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOMORPHINE TEST; APOPTOSIS; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; MACROPHAGE ACTIVATION; MALE; MESENCEPHALON; MICROGLIA; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RAT MODEL; SUBSTANTIA NIGRA PARS COMPACTA; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; METABOLISM; PARKINSON DISEASE, SECONDARY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINERGIC NEURONS; ENZYME ACTIVATION; GENISTEIN; GLUTATHIONE PEROXIDASE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MALE; MALONDIALDEHYDE; MICROGLIA; NADPH OXIDASE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84942860574     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.09.013     Document Type: Article

References (40)

1. S. Biradar, H. Joshi, and T. Chheda Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer's disease Hum. Exp. Toxicol. 1-14 2013
2. M.L. Block NADPH oxidase as a therapeutic target in Alzheimer's disease BMC Neurosci. 9 Suppl 2 2008 S8
3. R.M. Breikaa, M.M. Algandaby, E. El-Demerdash, and A.B. Abdel-Naim Multimechanistic antifibrotic effect of biochanin a in rats: implications of proinflammatory and profibrogenic mediators PLoS One 8 2013 e69276
4. A. Castaño, A.J. Herrera, J. Cano, and A. Machado The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α, IL-1β and IFN-γ J. Neurochem. 81 2002 150 157
5. H.Q. Chen, Z.Y. Jin, and G.H. Li Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation Neurosci. Lett. 417 2007 112 117
6. S.H. Choi, S. Aid, H.W. Kim, S.H. Jackson, and F. Bosetti Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation J. Neurochem. 120 2012 292 301
7. E.S. Chung, E. Bok, Y.C. Chung, H.H. Baik, and B.K. Jin Cannabinoids prevent lipopolysaccharide-induced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase Brain Res. 1451 2012 110 116
8. E.S. Chung, Y.C. Chung, E. Bok, H.H. Baik, E.S. Park, J.Y. Park, S.H. Yoon, and B.K. Jin Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress Brain Res. 1363 2010 143 150
9. Y.C. Chung, S.R. Kim, J.Y. Park, E.S. Chung, K.W. Park, S.Y. Won, E. Bok, M. Jin, E.S. Park, S.H. Yoon, H.W. Ko, Y.S. Kim, and B.K. Jin Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation Neuropharmacology 60 2011 963 974
10. Y.Q. Cui, Y.J. Jia, T. Zhang, Q.B. Zhang, and X.M. Wang Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia CNS Neurosci. Ther. 18 2012 827 833
11. D.T. Dexter, C.J. Carter, F.R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner, and C.D. Marsden Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J. Neurochem. 52 1989 381 389
12. H.-M. Gao, J. Jiang, B. Wilson, W. Zhang, J.-S. Hong, and B. Liu Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance of Parkinson's disease J. Neurochem. 81 2002 1285 1297
13. H.M. Gao, H. Zhou, and J.S. Hong NADPH oxidases: novel therapeutic targets for neurodegenerative diseases Trends Pharmacol. Sci. 33 2012 295 303
14. R. Harini, M. Ezhumalai, and K.V. Pugalendi Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats Eur. J. Pharmacol. 676 2012 89 94
15. A.J. Herrera, A. Castaño, J.L. Venero, J. Cano, and A. Machado The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system Neurobiol. Dis. 7 2000 429 447
16. M.C. Hernandez-Romero, S. Arguelles, R.F. Villaran, R.M. de Pablos, M.J. Delgado-Cortes, M. Santiago, A.J. Herrera, J. Cano, and A. Machado Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide J. Neurochem. 105 2008 445 459
17. L.F. Hu, M. Lu, C.X. Tiong, G.S. Dawe, G. Hu, and J.S. Bian Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models Aging Cell 9 2010 135 146
18. S.Z. Imam, and S.F. Ali Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation Brain Res. 855 2000 186 191
19. P. Jenner, and C.W. Olanow Understanding cell death in Parkinson's disease Ann. Neurol. 44 1998 S72 S84
20. W.-G. Kim, R.P. Mohney, B. Wilson, G.-H. Jeohn, B. Liu, and J.-S. Hong Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia J. Neurosci. 20 2000 6309 6316
21. M.M. Khan, A. Ahmad, T. Ishrat, M.B. Khan, M.N. Hoda, G. Khuwaja, S.S. Raza, A. Khan, H. Javed, K. Vaibhav, and F. Islam Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease Brain Res. 1328 2010 139 151
22. S. Koppula, H. Kumar, I.S. Kim, and D.K. Choi Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease Mediat. Inflamm. 2012 2012 823902
23. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci. 19 1996 312 318
24. W.Z. Li, W.Y. Wu, H. Huang, Y.Y. Wu, and Y.Y. Yin Protective effect of bilobalide on learning and memory impairment in rats with vascular dementia Mol. Med. Rep. 8 2013 935 941
25. B. Liu, and J.-S. Hong Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention J. Pharmacol. Exp. Ther. 304 2003 1 7
26. B. Liu, J.-W. Jiang, B.C. Wilson, L. Du, S.-N. Yang, J.-Y. Wang, G.-C. Wu, X.-D. Cao, and J.-S. Hong Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide J. Pharmacol. Exp. Ther. 295 2000 125 132
27. X. Lu, G. Bing, and T. Hagg Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats Neuroscience 97 2000 285 291
28. M. Padurariu, A. Ciobica, I. Dobrin, and C. Stefanescu Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics Neurosci. Lett. 479 2010 317 320
29. E.S. Park, S.R. Kim, and B.K. Jin Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress Brain Res. Bull. 89 2012 92 96
30. L. Qin, Y. Liu, T. Wang, S.J. Wei, M.L. Block, B. Wilson, B. Liu, and J.S. Hong NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia J. Biol. Chem. 279 2004 1415 1421
31. W.J. Tai, X. Ye, X. Bao, B. Zhao, X. Wang, and D. Zhang Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models Neuropharmacology 75 2013 201 212
32. J.W. Tan, C.L. Tham, D.A. Israf, S.H. Lee, and M.K. Kim Neuroprotective effects of biochanin A against glutamate-induced cytotoxicity in PC12 cells via apoptosis inhibition Neurochem. Res. 38 2013 512 518
33. S. Tanaka, M. Ide, T. Shibutani, H. Ohtaki, S. Numazawa, S. Shioda, and T. Yoshida Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats J. Neurosci. Res. 83 2006 557 566
34. Y.Y. Tian, L.J. An, L. Jiang, Y.L. Duan, J. Chen, and B. Jiang Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuronglia cultures Life Sci. 80 2006 193 199
35. D.C. Wu, P. Teismann, K. Tieu, M. Vila, V. Jackson-Lewis, H. Ischiropoulos, and S. Przedborski NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America, 100, 6145-6150 2003
36. Y. Yin, Y. Ren, W. Wu, Y. Wang, M. Cao, Z. Zhu, M. Wang, and W. Li Protective effects of bilobalide on Abeta(25-35) induced learning and memory impairments in male rats Pharmacol. Biochem. Behav. 106 2013 77 84
37. M.S. Yoo, H.S. Chun, J.J. Son, L.A. DeGiorgio, D.J. Kim, C. Peng, and J.H. Son Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease Brain Res. Mol. Brain Res. 110 2003 76 84
38. F. Zhang, J.S. Shi, H. Zhou, B. Wilson, J.S. Hong, and H.M. Gao Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions Mol. Pharmacol. 78 2010 466 477
39. F. Zhang, H. Zhou, B.C. Wilson, J.S. Shi, J.S. Hong, and H.M. Gao Fluoxetine protects neurons against microglial activation-mediated neurotoxicity Parkinsonism Relat. Disord. 18 Suppl 1 2012 S213 S217
40. H.-F. Zhou, X.-Y. Liu, D.-B. Niu, F.-Q. Li, Q.-H. He, and X.-M. Wang Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection Neurobiol. Dis. 18 2005 441 449